JUNB and Alzheimer disease: Such heterogeneity with respect to JunB expression was reported, for example, in Alzheimer’s disease, where JunB was expressed only in a specific population of an activated, highly phagocytic, stage 1 disease-associated microglia (DAM-1) [18].